Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Regentis Biomaterials EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Regentis Biomaterials's EV/EBITDA was 15.4× on Feb 27, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 15.4× | +13.6 |
| 2025 | Dec 31, 2025 | 1.8× | – |
See a number that looks wrong?